261896-47-3

Upstream product

• 93102-05-7 N-benzyl-N-(methoxymethyl)-N-[(trimethylsilyl)methyl]amine 
• 261896-46-2 (R,E)-3-(5-methylhex-2-enoyl)-4-phenyl-1,3-oxazolidine-2-one 
• 81530-29-2 (E)-5-methylhex-2-enoic acid chloride 
• 34993-63-0 5-methyl-2-hexenoic acid ethyl ester 
• 41653-96-7 5-methyl-2-hexenoic acid 
• 41653-96-7 (E)-5-methyl-2-hexenoic acid 

Downstream Products

• 261896-48-4 1-benzyl-4-(S)-isobutylpyrrolidine-3-(S)-carboxylic acid 
• 261896-39-3 (3S,4S)-4-(2'-methylprop-1'-yl)-3-pyrrolidine carboxylic acid 

Relevant academic research and scientific papers

Phosphodiesterase inhibitor, and applications thereof

The invention belongs to the technical field of medicine, and more specifically relates to a phosphodiesterase 9 (PDE9) inhibitor represented by formula I, and pharmaceutically acceptable salts, solvates, polymorphic substances, and isomers thereof, and also relates to medicinal preparations, and pharmaceutical compositions of the above compounds, and applications of the medicinal preparations andpharmaceutical compositions. The compounds and the pharmaceutically acceptable salts, solvates, polymorphic substances, and isomers can be used in treatment of phosphodiesterase 9 (PDE9) abnormal expression mediated related diseases.